- Home
- TRVI vs APOG Comparison
TRVI vs APOG Comparison
Compare TRVI & APOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- APOG
- Stock Information
- Founded
- TRVI 2011
- APOG 1949
- Country
- TRVI United States
- APOG United States
- Employees
- TRVI N/A
- APOG N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- APOG Auto Parts:O.E.M.
- Sector
- TRVI Health Care
- APOG Consumer Discretionary
- Exchange
- TRVI Nasdaq
- APOG Nasdaq
- Market Cap
- TRVI 725.7M
- APOG 818.5M
- IPO Year
- TRVI 2019
- APOG N/A
- Fundamental
- Price
- TRVI $7.42
- APOG $41.52
- Analyst Decision
- TRVI Strong Buy
- APOG Hold
- Analyst Count
- TRVI 9
- APOG 1
- Target Price
- TRVI $19.50
- APOG $45.00
- AVG Volume (30 Days)
- TRVI 1.8M
- APOG 176.1K
- Earning Date
- TRVI 08-07-2025
- APOG 10-03-2025
- Dividend Yield
- TRVI N/A
- APOG 2.49%
- EPS Growth
- TRVI N/A
- APOG N/A
- EPS
- TRVI N/A
- APOG 2.36
- Revenue
- TRVI N/A
- APOG $1,376,100,000.00
- Revenue This Year
- TRVI N/A
- APOG $6.91
- Revenue Next Year
- TRVI N/A
- APOG $0.41
- P/E Ratio
- TRVI N/A
- APOG $17.68
- Revenue Growth
- TRVI N/A
- APOG N/A
- 52 Week Low
- TRVI $2.36
- APOG $37.53
- 52 Week High
- TRVI $8.11
- APOG $87.93
- Technical
- Relative Strength Index (RSI)
- TRVI 59.47
- APOG 48.71
- Support Level
- TRVI $7.08
- APOG $40.11
- Resistance Level
- TRVI $7.74
- APOG $42.25
- Average True Range (ATR)
- TRVI 0.42
- APOG 1.00
- MACD
- TRVI -0.05
- APOG -0.17
- Stochastic Oscillator
- TRVI 55.77
- APOG 40.52
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About APOG Apogee Enterprises Inc.
Apogee Enterprises Inc is a provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. The company's operating segment consists of the Architectural Metals Segment, Architectural Services Segment, Architectural Glass Segment, and Performance Surfaces Segment. The company generates the majority of its revenue from the Architectural Metals Segment, which designs, engineers, fabricates, and finishes aluminum window, curtainwall, storefront, and entrance systems used principally in non-residential construction. The company generates revenue geographically from the United States, Canada, and Brazil, with the majority coming from the United States.